Article

COA Expresses Concern With Mandatory Radiation Oncology Model

In response to CMS’ announcement outlining the Radiation Oncology Alternative Payment Model, the Community Oncology Alliance (COA) has expressed concerns over the model being mandatory or “required” by the agency.

In response to CMS’ announcement outlining the Radiation Oncology Alternative Payment Model, the Community Oncology Alliance has expressed concerns over the model being mandatory or “required” by the agency. While they note that the model does include a much-needed policy proposal to implement site-neutral payment, they do not support mandatory models.

They add that if models are reasonable and advance value-based care, then voluntary provider participation will be robust and that mandatory models can subject patients with cancer and other serious diseases to disruptions in care that they need and are guaranteed and entitled to under Medicare.

Read the full press release.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo